| Preclinical Development of Bivalent Chimeric Antigen Receptors Targeting Both CD19 and CD22 |
36 |
| Oncolytic Viruses for Cancer Therapy: Barriers and Recent Advances |
28 |
| Oncolytic Viruses and Immune Checkpoint Inhibition: The Best of Both Worlds |
28 |
| 1 A Systematic Review of miR-29 in Cancer |
25 |
| B7-H3 as a Novel CAR-T Therapeutic Target for Glioblastoma |
25 |
| The Dual Role of Bone Morphogenetic Proteins in Cancer |
24 |
| Checkpoint Blockade Reverses Anergy in IL-13R alpha 2 Humanized scFv-Based CAR T Cells to Treat Murine and Canine Gliomas |
19 |
| Parallel Comparison of 4-1BB or CD28 Co-stimulated CD19-Targeted CAR-T Cells for B Cell Non-Hodgkin's Lymphoma |
18 |
| Oncolytic Virus-Based Cytokine Expression to Improve Immune Activity in Brain and Solid Tumors |
16 |
| CD19 CAR T Cells Expressing IL-12 Eradicate Lymphoma in Fully Lymphoreplete Mice through Induction of Host Immunity |
16 |
| Two-Dimensional Regulation of CAR-T Cell Therapy with Orthogonal Switches |
16 |
| Enhanced Delivery of Oncolytic Adenovirus by Neural Stem Cells for Treatment of Metastatic Ovarian Cancer |
15 |
| High Expression of Pseudogene PTTG3P Indicates a Poor Prognosis in Human Breast Cancer |
15 |
| The Enhanced Tumor Specificity of TG an Armed Oncolytic Vaccinia Virus Deleted in Two Genes Involved in Nucleotide Metabolism |
15 |
| Abscopal Effect in Non-injected Tumors Achieved with Cytokine-Armed Oncolytic Adenovirus |
14 |
| Measles Virus-Based Treatments Trigger a Pro-inflammatory Cascade and a Distinctive Immunopeptidome in Glioblastoma |
13 |
| Oncolytic Immunotherapy for Bladder Cancer Using Coxsackie A21 Virus |
12 |
| Enhancing Dendritic Cell Therapy in Solid Tumors with Immunomodulating Conventional Treatment |
11 |
| Restoring E-cadherin Expression by Natural Compounds for Anticancer Therapies in Genital and Urinary Cancers |
11 |
| The miR-195 Axis Regulates Chemoresistance through TUBB and Lung Cancer Progression through BIRC5 |
11 |
| Overexpression of microRNA-34a Attenuates Proliferation and Induces Apoptosis in Pituitary Adenoma Cells via SOX7 |
11 |
| ROS/KRAS/AMPK Signaling Contributes to Gemcitabine-Induced Stem-like Cell Properties in Pancreatic Cancer |
11 |
| miR-93 Promotes the Growth and Invasion of Prostate Cancer by Upregulating Its Target Genes TGFBR ITGB and LATS2 |
10 |
| Exosomal Leucine-Rich-Alpha2-Glycoprotein 1 Derived from Non-Small-Cell Lung Cancer Cells Promotes Angiogenesis via TGF-beta Signal Pathway |
10 |
| lncRNA UCA1-Mediated Cdc42 Signaling Promotes Oncolytic Vaccinia Virus Cell-to-Cell Spread in Ovarian Cancer |
10 |
| A Novel Chimeric Poxvirus Encoding hNIS Is Tumor-Tropic, Imageable, and Synergistic with Radioiodine to Sustain Colon Cancer Regression |
10 |
| The Expression of MicroRNA-598 Inhibits Ovarian Cancer Cell Proliferation and Metastasis by Targeting URI |
10 |
| Enhanced Safety and Efficacy of Oncolytic VSV Therapy by Combination with T Cell Receptor Transgenic T Cells as Carriers |
10 |
| Recombinant AAV-CEA Tumor Vaccine in Combination with an Immune Adjuvant Breaks Tolerance and Provides Protective Immunity |
9 |
| Skp2 Expression Is Inhibited by Arsenic Trioxide through the Upregulation of miRNA-330-5p in Pancreatic Cancer Cells |
9 |
| A Novel Oncolytic Chimeric Orthopoxvirus Encoding Luciferase Enables Real-Time View of Colorectal Cancer Cell Infection |
9 |
| Silencing LGR6 Attenuates Stemness and Chemoresistance via Inhibiting Wnt/beta-Catenin Signaling in Ovarian Cancer |
9 |
| Targeting Histone Methyltransferase DOT1L by a Novel Psammaplin A Analog Inhibits Growth and Metastasis of Triple-Negative Breast Cancer |
8 |
| MAPK Inhibitors Enhance HDAC Inhibitor-Induced Redifferentiation in Papillary Thyroid Cancer Cells Harboring BRAF(V600E) : An In Vitro |
8 |
| Endogenous Akt Activity Promotes Virus Entry and Predicts Efficacy of Novel Chimeric Orthopoxvirus in Triple-Negative Breast Cancer |
8 |
| Functional Gene Knockout of NRF2 Increases Chemosensitivity of Human Lung Cancer A549 Cells In Vitro and in a Xenograft Mouse Model |
8 |
| miR-424-5p Promotes Anoikis Resistance and Lung Metastasis by Inactivating Hippo Signaling in Thyroid Cancer |
8 |
| GBM-Targeted oHSV Armed with Matrix Metalloproteinase 9 Enhances Anti-tumor Activity and Animal Survival |
8 |
| Combined Checkpoint Inhibition and Chemotherapy: New Era of 1st-Line Treatment for Non-Small-Cell Lung Cancer |
8 |
| Expression and Prognosis Analyses of Runt-Related Transcription Factor Family in Human Leukemia |
7 |
| A Retroviral Replicating Vector Encoding Cytosine Deaminase and 5-FC Induces Immune Memory in Metastatic Colorectal Cancer Models |
7 |
| Myelolytic Treatments Enhance Oncolytic Herpes Virotherapy in Models of Ewing Sarcoma by Modulating the Immune Microenvironment |
7 |
| Oncolytic Virus-Mediated RAS Targeting in Rhabdomyosarcoma |
7 |
| Sulforaphane Induces miR135b-5p and Its Target Gene, RASAL thereby Inhibiting the Progression of Pancreatic Cancer |
7 |
| Matrix Metalloproteinase 11 Is a Potential Therapeutic Target in Lung Adenocarcinoma |
7 |
| Exosomes Carrying MicroRNA-155 Target Forkhead Box O3 of Endothelial Cells and Promote Angiogenesis in Gastric Cancer |
7 |
| Dual Regulatory Mechanisms of Expression and Mutation Involving Metabolism-Related Genes FDFT1 and UQCR5 during CLM |
7 |
| Inflammatory Micro-environment Contributes to Stemness Properties and Metastatic Potential of HCC via the NF-kappa B/miR-497/SALL4 Axis |
6 |
| Effective Therapy Using a Liposomal siRNA that Targets the Tumor Vasculature in a Model Murine Breast Cancer with Lung Metastasis |
6 |
| Enhanced Therapeutic Efficacy of a Novel Oncolytic Herpes Simplex Virus Type 2 Encoding an Antibody Against Programmed Cell Death 1 |
6 |
